Seoul National University Bundang Hospital

Medicine & Life Sciences

1. Korea 100%
2. Neoplasms 51%
3. Therapeutics 43%
4. Stomach Neoplasms 43%
5. Survival 40%
6. Confidence Intervals 37%
7. Stroke 33%
8. Republic of Korea 33%
9. Recurrence 30%
10. Population 30%
11. Mortality 27%
12. Cohort Studies 27%
13. Odds Ratio 26%
14. Magnetic Resonance Imaging 26%
15. Helicobacter pylori 26%
16. Child 26%
17. Incidence 25%
18. Elderly 25%
19. Safety 25%
20. Tomography 25%
21. Eye 25%
22. Breast Neoplasms 25%
23. Multicenter Studies 24%
24. Mutation 24%
25. Non-Small Cell Lung Carcinoma 23%
26. Genes 23%
27. Serum 23%
28. Neoplasm Metastasis 22%
29. Seoul 22%
30. Drug Therapy 22%
31. Registries 21%
32. Lung 20%
33. Stents 20%
34. Randomized Controlled Trials 20%
35. Hepatocellular Carcinoma 20%
36. Prostatic Neoplasms 20%
37. Hip 19%
38. Retrospective Studies 18%
39. Liver 18%
40. Kidney 18%
41. Prospective Studies 17%
42. Thigh 17%
43. Genotype 16%
44. Biopsy 16%
45. Prostatectomy 16%
46. Gastrectomy 16%
47. Myocardial Infarction 16%
48. Stomach 16%
49. Bone and Bones 16%
50. Multivariate Analysis 16%
51. Lung Neoplasms 15%
52. Colorectal Neoplasms 15%
53. Pain 15%
54. Transplants 15%
55. Meta-Analysis 15%
56. Wounds and Injuries 14%
57. Type 2 Diabetes Mellitus 14%
58. Lymph Nodes 14%
59. Control Groups 14%
60. Muscles 14%
61. Spine 14%
62. Body Mass Index 14%
63. Hemorrhage 13%
64. Coronary Artery Disease 13%
65. Injections 13%
66. Guidelines 13%
67. Laparoscopy 12%
68. Glucose 12%
69. Regression Analysis 12%
70. Asthma 12%
71. Rotator Cuff 12%
72. Brain 12%
73. Propensity Score 12%
74. Pediatrics 12%
75. University Hospitals 12%
76. Renal Cell Carcinoma 12%
77. Thorax 12%
78. Blood Pressure 12%
79. Skin 12%
80. Logistic Models 12%
81. Osteotomy 12%
82. Pathologic Constriction 11%
83. Nutrition Surveys 11%
84. Radiotherapy 11%
85. Chronic Renal Insufficiency 11%
86. Positron-Emission Tomography 11%
87. Knee 11%
88. Blood Vessels 11%
89. Biomarkers 11%
90. Prostate 11%
91. Carcinoma 11%
92. Quality of Life 11%
93. Obstructive Sleep Apnea 11%
94. Pharmaceutical Preparations 11%
95. Helicobacter Infections 11%
96. Ultrasonography 11%
97. Progression-Free Survival 11%
98. Survival Rate 11%
99. Optical Coherence Tomography 11%
100. Percutaneous Coronary Intervention 10%